OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0960-AG57         View EO 12866 Meetings	Received Date: 08/03/2009
Title: Revised Medical Criteria for Evaluating Malignant Neoplastic Diseases (3429F)
Agency/Subagency: SSA	Stage: Final Rule
Concluded Action: Consistent without Change	Concluded Date: 09/25/2009
Legal Deadline: None	Economically Significant: No
Publication Date: 10/06/2009	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected: No
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: Uncollected
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: Uncollected
Pandemic Response: Uncollected